“In order to be commercially successful it is essential to facilitate the introduction of innovative biobased products on the market. This means ensuring the implementation of the Priority Recommendations from the Lead Market Initiative, to boost the uptake of innovative biobased products on the European market. A good example from the US, in this respect, is the Biopreferred programme, which was established to ensure that US policy is aiding sustainable biobased industries to have a competitive edge through public procurement initiatives. Additionally, we need to foster investments through combined financing”. To say this – in this exclusive interview with Il Bioeconomista – is Nathalie Moll, Secretary General of EuropaBio, the European Association for Bioindustries. With Moll we discuss about bioeconomy in Europe and the next edition of EFIB, the European Forum for Industrial Biotechnology and Bio-based economy, which will take place in Reims (France) from 30 September to 2 October. “This years’s EFIB – says Moll – will provide the forum for dynamic discussion around the year’s biggest and best joint ventures, with high profile consumer brands. It will also provide a snapshot of how policy is being put into practice through the most significant developments in scale up of commercial biorefineries around the world”.
Interview by Mario Bonaccorso